67.3% of Hyperhidrosis Patients Unaware of Insurance Eligibility for Botox|Experts Explain Treatment Duration and Costs Based on 2,000+ Cases

Icy Clinic surveyed hyperhidrosis patients, revealing that 67.3% do not know the insurance eligibility criteria for Botox. Cost anxiety is the top barrier to treatment. The clinic released a comparative analysis of treatments by specialists.
調査NQ 85/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 28, 2026 at 09:00
  • 🔍 Collected: June 1, 2026 at 00:50 (87h 50m after Published)
  • 🤖 AI Analyzed: June 1, 2026 at 23:48 (22h 58m after Collected)
## Survey Key Findings
If diagnosed with primary focal hyperhidrosis, Botox injections for the underarms are covered by insurance with a 30% copay, costing approximately 20,000–30,000 yen, with effects lasting an average of 4–9 months. Treatment for palms and soles is available but not covered by insurance. The difference from Miradry is that Botox is a convenient injection with temporary effects, while Miradry can provide long-term results in a single session.

- 67.3% of patients are unaware of the exact insurance eligibility criteria.
- 82.4% of those who have undergone Botox treatment reported experiencing its effectiveness.
- The primary reason for hesitating to seek treatment is 'anxiety about cost' at 43.7%.

## Glossary
■ Botulinum Toxin (Botox)
A pharmaceutical product derived from protein produced by the botulinum bacterium. It temporarily blocks nerve signals to sweat glands, suppressing sweating. It is approved for insurance coverage in hyperhidrosis treatment.

■ Primary Focal Hyperhidrosis
A condition involving excessive sweating in specific areas (underarms, palms, soles, face) without an underlying medical cause. It is eligible for insurance coverage if criteria such as symptoms persisting for over 6 months and impairment of daily life are met.

■ Miradry
A treatment using medical devices that use microwave energy to destroy sweat glands. It is a non-incisional, FDA-approved treatment that promises long-term results in one session.

## Hyperhidrosis Treatment Comparison: Botox vs. Miradry
| Comparison | Botox Injection | Miradry |
| :--- | :--- | :--- |
| Duration | 4–9 months (varies) | Long-term (semi-permanent) |
| Cost (Underarm) | 20,000–30,000 yen (30% copay) | 250,000–400,000 yen (Out-of-pocket) |
| Treatment Time | Approx. 10–15 mins | Approx. 60–90 mins |
| Downtime | Virtually none | 2–3 days swelling/pain |
| Sessions | 1–2 times per year | Typically once |
| Areas | Underarms, hands, feet, face, etc. | Underarms only |
| Scars | Injection marks only (fade quickly) | None |

Icy Clinic, operated by the Medical Corporation Tetsuketsukai, conducted a survey on hyperhidrosis treatment. Under the supervision of Dr. Kota Takakuwa (15+ years of experience in dermatological surgery, 2,000+ cases), the clinic aims to provide useful information for treatment decision-making.

FAQ

脇の多汗症に対するボトックス注射の費用はどのくらいですか?

原発性局所多汗症と診断された場合、保険適用(3割負担)となり約2〜3万円で治療可能です。

ボトックス注射の効果はどのくらい持続しますか?

個人差はありますが、平均して4〜9ヶ月程度持続します。

多汗症の治療でボトックス注射とミラドライはどう違いますか?

ボトックスは注射で手軽に行えますが効果は一時的です。一方、ミラドライはマイクロ波で汗腺を破壊するため、1回で長期的な効果が期待できます。

保険適用を受けるための条件は何ですか?

原発性局所多汗症の診断基準を満たす必要があります。具体的には、特定の原因疾患がなく、脇などの特定部位に過剰な発汗が生じ、6ヶ月以上の症状持続や日常生活への支障がある場合などが対象です。

多汗症治療を躊躇する一番の理由はなんですか?

調査の結果、治療を躊躇する理由の1位は「費用への不安」で、全体の43.7%を占めています。